Navigation Links
Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
Date:1/25/2009

need for safe and effective treatments for drug resistant bacterial infections in the hospital and in the community."

About Trius Therapeutics

Trius Therapeutics is discovering and developing innovative antibacterial drugs for the treatment of infections caused by drug-resistant pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against drug-resistant Gram-positive bacterial pathogens including those resistant to Zyvox(R), the only marketed antibacterial drug of the oxazolidinone class. Trius has licensed worldwide rights outside of Korea to torezolid from Dong-A Pharmaceuticals. Trius' pipeline includes two preclinical programs with lead candidates being developed to treat serious infections caused by Gram-negative bacterial pathogens. For more information, visit www.triusrx.com.


'/>"/>
SOURCE Trius Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
2. PacificGMP Completes GMP Product Fill for Trius Therapeutics
3. Trius Doses First Patient in Antibacterial Phase 2 Trial
4. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
11. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...HAM, Mass., Dec. 2 Decision Resour...ory firms for pharmaceutical and healthcare issues...d branded atypical antipsychotics will cause the s...lion in 2008 to $5.2 billion in 2013 in the United... Kingdom and Japan. ,, The new Pharmacor report...
(Date:12/2/2009)...VILLAGE, Nev., Dec. 2 PD...ounced that it has established the per share amoun... dividend as $1.67 per share. The dividend will be...ompany,s stock as of the December 1, 2009 record d...te per share amount of the dividend at $1.67 per s...
(Date:12/2/2009)... NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Simce...") (NYSE: SCR ), a leading pharmaceutical compan...and marketing of branded,generic and proprietary p...ubsidiary Jiangsu Yanshen Biological Technology St...oduction of all its products in order to conduct a...
Breaking Medicine Technology:Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Reduced Radiation Heart Scans Dont Compromise on Quality 48370 1Reduced Radiation Heart Scans Dont Compromise on Quality 48370 2Randall Terry 3A How Tillers Death and office Closing Can Help Propel Pro Life Movement Derail Sotomayor and Overturn Roe 3B Four Key Senators Will B 48366 1Randall Terry 3A How Tillers Death and office Closing Can Help Propel Pro Life Movement Derail Sotomayor and Overturn Roe 3B Four Key Senators Will B 48366 2VBI researchers develop new method for breast cancer biomarker discovery 48362 1VBI researchers develop new method for breast cancer biomarker discovery 48362 2
(Date:12/2/2009)...wswire/ - As part of its continued commitment to h... of Pfizer, has pledged more than 40 million inter... World Federation of Hemophilia (WFH). This is the...ian Aid Program, and will make a significant impac... will directly support building sustainable nation...
(Date:12/2/2009)... Independence Blue Cross (IBC) toda...Lincoln Financial Group. IBC will be the primary p...00 Lincoln Financial Group employees, retirees, an...plan offerings will include the PPO option and Com...eak for all of us at Independence Blue Cross when ...
(Date:12/2/2009).... 2 TeamHealth ( www.teamhealth.co... the acquisition of Naples-based Emergency Physici... has held an exclusive contract with NCH Healthcar...Downtown Naples Hospital, North Naples Hospital, a...the staffing for two stand-alone urgent care clini...
(Date:12/2/2009)...sports. An avid tennis player and golfer, as well ...ecame increasingly frustrated over time as his eye...e disorder. Unable to return the tennis ball or se...t of a corneal transplant to restore his vision an...iscovered an alternative treatment. He received a ...
(Date:12/2/2009)...ngress of the European Association of Echocardiogr...ciety of Cardiology, where techniques of non-invas... case reports will be presented at this year,s Con...ole of this new technology. , Now, with such ra...y that non-invasive imaging will gain more importa...
Breaking Medicine News(10 mins):Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:Media alert: EUROECHO 2009 2
...ughter Nicole's drastic weight loss that he agreed...t the problem.// According to contactmusic.c...d wanted to know if she had an eating disorder. ...ly an eating disorder?' Because we went to a coupl...
...th of illegal abortions, said she will not contest...th Wales (NSW) Medical// Tribunal. Suman Soo... according to the Sydney Morning Herald newspaper....unsel Mr Phillip Boulten and Mr Michael Fordham's ...
...ued a warning about substandard contraceptive devi...fficials have pinned// down nearly eight doctors f...parties and Internet vendors. Dr. Mark Hort...pproved IUDs from FDA-approved sources. The fact t...
...o change E. coli bacteria, a class of micro-organi...ways that render them unable to// initiate an infe...r Polytechnic Institute (WPI), Massachusetts, sugg...d science portal EurekAlert. E. Coli is a ge...
...s proposals to introduce picture warnings on tobac... packets illustrating the damage caused by smoking...king related diseases in Wales, doctors' leaders s...he British Medical Association has led the campaig...
...ve a new tool in the fight against breast cancer, ... doctors// in other areas improve diagnoses for ye...e past several months Dr. William Smith and Dr. Ma...or breast cancer patients. Smith said he is amazed...
Other Medicine News:
Autocrit Ultra
Spinchron 15
The Clipper
The Wiggler Display
Medicine Products: